







240 SThe association of acute aortic
dissection with Helicobacter pylori
virulence specific serotypes: Distinct
diversity of systemic antibodies to CagA
and VacA genotypes
Vito Antonio Mannacio, MD, Vincenzo De Amicis, MD, Luigi Di Tommaso, MD, Paolo Stassano, MD,
Francesco Iorio, MD, and Carlo Vosa, MD, Naples, Italy
Background. Previous studies reported an association between chronic Helicobacter pylori infection and
cardiovascular disease; however, controversy still exists regarding the presence of bacterial genomic
material in atherosclerotic plaques. Currently, the genetic polymorphisms of H. pylori have been
investigated and many virulence factors have been identified. No one has tried to associate these
polymorphisms with aortic dissections. This study evaluated whether more virulent strains of H. pylori
represent a risk factor for acute ascending aorta dissections.
Methods. The serologic status for H. pylori and type I strains were determined in 100 patients who
underwent operative repair of acute, ascending aorta dissection and in 100 population-based control
subjects matched fully for clinical, demographic, and socioeconomic characteristics. The specimens from
dissected aorta were evaluated to identify the presence of bacterial genomic material in surgical patients.
Results. No evidence of genomic material from H. pylori was found in the specimens. The prevalence of
positive H. pylori serology was greater in patients than in controls (72 vs 50) with an adjusted odds ratio
2.8 (95% confidence interval, 1.8--4.1; P = .006). Patients with aortic dissection also had a greater
prevalence of vacuolating cytotoxin gene subtypes s1m1 (73% vs 31%) with an odds ratio of 6.0 (95%
confidence interval, 3.1--11; P < .001). Patients who were positive for vacuolating cytotoxin gene
subtypes s1m1 were similar in demographic and clinical features compared with other patients.
Conclusion. The findings provide support for the hypothesis that an association exists between the
more virulent type I strains of H. pylori (vacuolating cytotoxin gene subtypes s1m1) infection and acute
aortic dissection. The mechanism(s) underlying the association remain to be elucidated. (Surgery
2011;149:240-6.)From the Department of Cardiac Surgery, University of Naples Federico II, Naples, ItalyMULTIPLE EXPERIMENTAL AND CLINICAL STUDIES have
suggested that infection by Helicobacter pylori may
have a role in the pathogenesis of cardiovascular
diseases.1-4 The possible mechanistic link between
chronic H. pylori infection and cardiovascular dis-
eases has been debated intensely. Previous studies
investigating the presence of H. pylori organisms
or genomic material from the pylori bacteria
within arterial wall or atherosclerotic plaques
provided contradictory results.5-9 Conversely, otherd for publication June 11, 2010.
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URGERYseroepidemiologic studies suggested that systemic
inflammatory diseases caused by chronic infection
with H. pylori may have a role in the pathogenesis
of ischemic heart disease. Mendall et al1 first
reported serologic evidence of a link between
H. pylori seropositivity and coronary heart dis-
eases.1 H. pylori seemed to be a possible indepen-
dent risk factor for coronary heart disease. More
recent studies produced conflicting findings that
were explained, at least in part, by the inclusion
of different risk factors and by the genetic poly-
morphism of H. pylori. Currently, evidence suggests
that distinct variants of H. pylori exist, which may be
associated with different aspects of bacterial
pathogenicity.10
Several H. pylori virulence genes that may play
a role in its pathogenicity have been identified.
Of these, the most important determinants are
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associated gene (CagA). H. pylori strains have
been divided into 2 broad families, type I and
type II, which are based on whether they possess
the VacA and CagA genes. Type I strains produce
VacA and CagA, whereas type II lacks the CagA
gene and presents a nontoxic form of VacA. Type
I strains are regarded as having greater pathoge-
nicity and greater potential to cause development
of diseases.
The CagA gene codes for CagA protein, which is
highly immunogenic and is related to a high level
of some cytokines.
The VacA gene encodes a proteinaceous,
vacuolating toxin that damages cells by induc-
tion of intracellular vacuolar formation. The
VacA gene is present in all H. pylori strains and
includes 2 variable regions. The s region (encod-
ing the signal peptide) exists as an s1 or s2
allele. The m region (middle) occurs as an m1
or m2 allele.11-13 The mosaic combination of
the 2 regions, s- and m-region allelic types, ex-
presses all possible combinations, implies the
existence of several subtypes, and determines
the production of the cytotoxin associated
with pathogenicity of the bacterium.12,14,15 VacA
s1/m1 strains produce large amounts of toxin,
s1/m2 strains produce moderate amounts, and
s2/m2 strains produce little or no toxin. The
VacA s1/m1 strain is thought to be associated
with more severe pathologies.15,16 Different sub-
types of type I H. pylori can be identified on
the basis of the VacA polymorphism, as an ex-
pression of mosaic combination.
Based on this concept, several recent studies
provided seroepidemiologic evidence indicating
that the H. pylori strains expressing the CagA may
serve as an independent marker of ischemic heart
disease.17-23 None of these studies, however, which
evaluated only 1 specific strain of H. pylori, consid-
ered the possible pathogenic link between H. pylori
infection and cardiovascular diseases taking into
account its genetic polymorphism.
So far, no data are available in the literature
documenting the relationship between both CagA
and VacA H. pylori strains (and their subtypes) and
vascular disease or acute aortic dissection. The
current study was designed to evaluate whether
virulent CagA and VacA positive H. pylori strains
are associated with acute, ascending aorta
dissections. Therefore, we aimed to confirm the
presence of CagA and the VacA, s and m subtypes,
in 100 patients who underwent operative repair for
acute ascending aorta dissection with an homoge-
neous group of control subjects. Furthermore, allthe specimens from surgical excision were ana-
lyzed for the presence of H pylori genomic material.
METHODS
Patient selection. Between January 2007 and
May 2008, 100 consecutive patients admitted for
surgical treatment of acute dissection of ascending
aorta were investigated. To avoid any misleading
interference, exclusion criteria were as follows:
aortic dissection caused by Marfan Syndrome (di-
agnosed when the rigorously applied Ghent crite-
ria were fulfilled),24 aortic dissections related to
coarctation of the aorta and/or previous signifi-
cant aortic valve disease (stenosis, incompetence,
with or without calcification), bicuspid aortic valve,
aortic root calcification, and cocaine use. Preoper-
ative evaluation by computed tomography or mag-
netic resonance imaging was performed in all
patients. According to the De Bakey classification,
85 patients had a type I aortic dissection and 15
had a type II dissection. Patients with type III
aortic dissection were excluded from the study as
well, because they usually underwent a different
approach. At admission, 27 patients were hemodi-
namically unstable, and 8 patients had evidence of
organ malperfusion. Standardized interviews ad-
dressing medical history, hypertension, diabetes,
current medication, history of gastritis or peptic
ulcers, sociodemographic data, and lifestyle were
carried out in all patients and/or their families.
Treatment of the dissecting lesion was by operative
repair in all patients.
The control group was enrolled after all 100
operative procedures had been performed in the
patient group. To avoid any misleading interfer-
ence, the control group consisted of 100 healthy
volunteers selected carefully to be truly compara-
ble with the patient group with the ascending,
aortic dissections. From a database of 18,000
patients charged by 18 family doctors of National
Health Service who provided their collaboration,
400 subjects were identified as matched fully to
patients group regarding geographic area, sex,
age, body weight, body mass index, history of
myocardial infarction, main risk factors for aortic
dissection (hypercholesterolemia, hypertension,
diabetes), history of documented peptic ulcer,
smoking status, physical activity, and overall social
status. Among these eligible subjects, 377 provided
informed consent to be enrolled in the study and
underwent subsequent selection by standardized
interview to obtain 100 controls who were matched
fully to patients.
Socioeconomic status was assessed according to
the Four Factor Index of Social Status reported by
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of socioeconomic level according to 4 factors: mar-
ital status, occupation, education, and retirement.
The status score of a nuclear family unit is calcu-
lated by multiplying the scale value for occupation
by a weight of 5 and the scale value for education
by a weight of 3 (the overall factor weights were cal-
culated with multiple regression equations). The
instrument was enriched by taking the fathers’
occupations at the time of birth into account
(classified as manual or non manual as indications
of childhood living conditions),26 current patient
occupation (categorized as class I professionals,
class II managerial and technical occupations, class
III subdivided into non-manual and manual skilled
workers, and class IV unskilled manual), and edu-
cation level (identified as none, school, further,
or university). The resulting computer scores
ranged from 120 (high) to 15 (low).
The history of peptic ulcers was considered
only when clinically documented to avoid any pos-
sible bias from clinical interview. Subsequent ex-
clusion criteria in both groups were nonsteroidal
anti-inflammatory drugs and/or protonpump in-
hibitors, and/or antibiotics treatment within the
previous 4 weeks.
Informed consent was obtained from all pa-
tients and the control group, and the protocol was
approved by the Hospital Ethic Committee and by
the hospital Institutional Review Board.
Biochemical measurements. Venous blood sam-
ples were collected in surgical patients at hospital
admission and in control subjects at the time of
enrollment. All blood samples were cooled imme-
diately to 4C and centrifuged (3,000 g for 10 min
at 4C). The plasma was separated and stored at
--70C until assay. Total anti-H. pylori antibodies
were determined using an enzyme-linked immuno-
sorbent assay commercial kit (Helicobacter pylori
immunoglobulin G; Diamedix Co., Miami, FL) ac-
cording to the manufacturer’s instructions. Titers
were judged positive when >24 U/mL (sensitivity
and specificity >98%). Immunoglobulin G anti-
body profiles were determined by Helicoblot
versions 2.1 (Genelabs Diagnostics, Singapore)
according to the manufacturer’s instructions
(96% sensitivity and 95% specificity). The Helico-
blot assays were based on a Western blot analysis
of whole-cell H. pylori antigens. The interpretation
of the serologic reactivity was restricted to antigens
of various molecular masses. Version 2.1 contained
antigens of 19.5, 30, 35, 37, 89 (VacA), and 116
(CagA) kDa. For Helicoblot 2.1, the criteria for
H. pylori seropositivity were as follows: (1) positive
result for the 116-kDa (CagA) band, where CagAhas to be present with 1 or more bands at the po-
sitions 89 (VacA), 37, 35, 30 (UreA), and 19.5 kDa
together, or with current infection marker (CIM);
(2) the presence of any 1 band at 89, 37, or 35
kDa, with or without the CIM; and (3) the pres-
ence of both the 30- and 19.5-kDa bands, with or
without the CIM. This kit allows rapid visualization
of full serologic profiles of various antigens that
belong to H. pylori and standardization for interna-
tional comparisons.27
Fasting total serum cholesterol and high density
lipoprotein (HDL) concentrations were also mea-
sured. Hypercholesterolemia was defined as a total
serum cholesterol >200 mg/dL, and HDL values
were considered normal when >80 mg/dL. We did
not take into account leukocyte count, fibrinogen,
or other markers of inflammatory process because
of their natural activation in all cases of acute
aortic root dissection.
Detection of H. pylori DNA. After operative
resection of the aneurysm, aortic wall specimens
collected from the anterior and posterior wall of
the ascending aorta were separated with sterile
scalpel blades into multiple sections of about
0.3 cm2 each and frozen at --20C. For each pa-
tient, 1 sample from the anterior aortic wall and
1 from the posterior wall were analyzed. The tissue
samples were digested by incubation for 3 h at
52C in 500 mL of digestion buffer (10 mmol/L
Tris pH, 8.5), 1 mmol/L ethylenediaminetetraace-
tic acid, and 0.5% sodium dodecyl sulfate contain-
ing 300 mg/mL of proteinase K. DNA purification
from digested tissues using a spin-column DNA
purification kit (Invitek GmbH, Berlin, Germany).
H. pylori DNA in the samples was detected by using
real-time, fluorometric, polymerase chain reaction
(PCR), directed to amplify the 23S rRNA gene.
PCR was performed in an ABI Prism 7000
Sequence Detection System (Applied Biosystems,
Foster City, CA). The amplification protocol in-
cluded 10 min incubation at 95C for denatura-
tion, and enzyme activation and 48 cycles of
denaturation at 95C for 15 s and extension
at 60C for 90 s. DNA extracted from cultured
H. pylori J99 cells was used as positive amplification
control. To exclude the possibility of the presence
of Taq polymerase inhibitors, H pylori was added
to negative samples that were then reanalyzed.
No evidence of inhibition was found. The results
were analyzed with the software of the device.
Additionally, all specimens were examined micro-
scopically for evidence of H. pylori organisms.
End points. The primary end point of this study
was the relationshipbetween type I strainsofH.pylori
and acute ascending aorta dissection. Secondary
Table I. Important clinical and demographic




(n = 100) P value
Age, years 64 ± 9 64 ± 9 Matched
Males 90 90 Matched
BMI (kg/m2) 27 ± 2 27 ± 2 Matched
Previous MI 3 3 Matched
Total cholesterol
(mg/dL)
190 ± 31 194 ± 29 .3
HDL (mg/dL) 68 ± 23 62 ± 32 .1
Creatinine (mg/dL) 1.4 ± 0.6 1.0 ± 0.3 .05
History of hypertension 50 50 Matched





Ex-smokers 16 16 Matched
Current smokers 32 32 Matched
Socioeconomic status 61 ± 19 59 ± 17 .4
Physical activity 33 33 Matched
Values are mean ± SD or numbers (percentages). Socioeconomic status
is assessed by Hollingshead modified index from 120 to 15 (low, 15--45;
medium, 46--80; and high, 81--120).
BMI, Body mass index; MI, myocardial infarction.
Table II. Important clinical and demographic
characteristics of patients and controls positive for




(n = 29) P value
Age, years 64 ± 7 65 ± 4 .5
Males 55 (90%) 26 (90%) 1
BMI (kg/m2) 28 ± 3 27 ± 2 .1
Previous MI 2 (3%) 1 (3%) 1
Total cholesterol
(mg/dL)
182 ± 32 189 ± 25 .3
HDL (mg/dL) 72 ± 23 69 ± 31 .8
Creatinine (mg/dL) 1.3 ± 0.5 1.0 ± 0.3 .03
History of hypertension 31 (50%) 15 (51%) .8
History of diabetes 11 (18%) 4 (14%) .8
History of peptic ulcer 4 (6.5%) 3 (10.3%) .8
Smoking status
Ex-smokers 10 (16%) 7 (24%) .2
Current smokers 25 (41%) 12 (41%) .8
Socioeconomic status 49 ± 18 56 ± 19 .09
Physical activity 20 (32%) 9 (31%) .9
Values are mean ± SD or numbers (percentages). Socioeconomic status
is assessed by Hollingshead modified index from 120 to 15 (low, 15--45;
medium, 46--80; and high, 81--120).
BMI, Body mass index; MI, myocardial infarction.
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gressive subtypes of type I H. pylori among to VacA
strains and the assessment of presence of H pylori
genomic material in dissected aorta.
Statistical analysis. As reported previously, evi-
dence of CagA and VacA strains of H. pylori in
asymptomatic healthy subjects is about 30--40%.28
Serologic evidence of more virulent H. pylori
strains was found in 50% of patients with docu-
mented coronary heart disease.20,23 Thus, a sample
of 100 patients and 100 controls would provide up
to 95% power to detect the difference (30--50%)
with a a of .05. Continuous variables were ex-
pressed as mean ± standard deviation (SD), and
categorical data as proportion. A comparison be-
tween continuous variables in the 2 groups was
made by means of the Student t test for normally
distributed features values. The Mann-Whitney U
test was used for variables not normally distributed.
The categorical variables were analyzed with the v2-
test or Fisher exact test. Variables with P values less
than .05 were considered significant. Odds ratio
(OR) and 95% confidence intervals (CI) assessing
the risk of aortic dissection associated with infec-
tion or by CagA and/or VacA strains positive H. py-
lori were evaluated by multiple logistic regression,
when necessary adjusted for age, sex, body mass in-
dex, history of hypertension, smoking or diabetes,
presence of hypertension or hypercholesterolemia,and socioeconomic status. An a value of <.05 (2-
tailed) was considered significant. Both univariate
(independent sample t test and v2) and multivari-
ate analyses (multivariate regression and logistic
regression) were performed using SPSS version
13.0 for Windows (SPSS Inc., Chicago, IL).
RESULTS
Study population. The general and clinical fea-
tures of patients and controls are summarized in
Table I. Because of matching, both groups were
similar in all important clinical and demographic
features. The only significant difference between
patients and controls were in creatinine values
which were >2.2 mg/dL in malperfused patients.
Detection of H. pylori genomic material. In all
100 patients evaluated, PCR showed no evidence of
the presence of H. pylori genomic material or infec-
tions in aortic aneurysm specimens.
Serological status. Seventy-two surgical patients
and 50 control subjects were seropositive for
H. pylori (OR, 2.5; 95% CI, 1.3--4.8; P = .002).
The association remains significant after adjust-
ment for age, sex, social class, and risk factors for
aortic dissection (OR, 2.8; 95% CI, 1.8--4.1; P =
.006). Patients who were either seropositive or se-
ronegative for H. pylori infection were similar in
age, sex, body mass index, and prevalence of risk
Figure. Results of multivariate analysis for more virulent strains of H. pylori in patients and controls.
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patients tended to come from a lower socioeco-
nomic status. Type I H. pylori (CagA+ and VacA+)
was identified in 61 of 72 seropositive patients
(85%) and in 29 of 50 control subjects (58%;
OR, 4.1; 95% CI, 1.5--10.3; P = .001). The associa-
tion remained significant after adjustment for
age, sex, social class, body mass index, and risk
factors for aortic dissection (OR, 3.8; 95% CI,
1.3--11.5; P < .001). No significant differences
were recorded between the 2 groups in the impor-
tant clinical or demographic features (Table II).
When we considered the s and m subtypes of the
VacA strains, 90% (55/61) of the patients in the
surgical group were s1 and 38% (23/61) were
m2. The combinations s1-m1, s1-m2, and s2-m2
were present in 73%, 17%, and 10% of strains in
the surgical group, respectively, and in 31%,
20%, and 49%, respectively, in the control group.
The more frequent (and considered the most viru-
lent) combination s1-m1 in the surgical patient
group compared with control subjects had an OR
of 6.25 (95% CI, 2.1--18.7; P < .001; Fig). The asso-
ciation remained significant after adjustment for
age, sex, body mass index, prevalence of risk fac-
tors for aortic dissection, and socioeconomic status
(OR, 5.9; 95% CI, 1.9--16.9; P < .001). In the pa-
tients group, patients who were VacA s1m1 strains
positive were similar for clinical and demographic
features compared with patients who were VacA
s1m1 strains negative. Patients who were VacA
s1m1 strains positive were older (P = .001),
more frequently male (P = .04), and came from
a lower socioeconomic status (P = .008) com-
pared with other patients (Table III). A multivar-
iate analysis of patients who were VacA s1m1 stain
positive confirmed that only age >65 years (OR,
1.61; 95% CI, 1.12--2.51; P = .02) and Hollings-
head modified index <50 (OR, 2.58; 95% CI,1.61--4.61; P = .006) were associated with seropos-
itivity for the VacA s1m1 positive strains.
Seropositivity for H. pylori was detected in 4 of 5
patients and 3 of 4 controls with history of peptic
ulcers (P = .5). All patients and controls seroposi-
tive for H. pylori with history of peptic ulcers were
type I positive and VacA s1m1 strains positive.
There was no prevalence of serologic status regard-
ing the type of dissection; the combination s1-m1
was present in 75% and in 64% (P = .6) of patients
with type I and type II aortic dissection,
respectively.
DISCUSSION
This case-control study provides strong evidence
that infection by the more virulent strains of H. py-
lori is associated with acute ascending aorta dissec-
tion. Systematic reviews of epidemiologic studies
suggested the existence of a strong positive rela-
tionship between cardiovascular disease and
chronic H. pylori infection.1-7 Several reports
showed clearly that cytotoxic strains of bacterium
bearing the CagA play a key role in the pathogen-
esis of cardiovascular diseases.17-23 Currently,
different H. pylori strains can be distinguished by
genotyping of virulence-associated gene, such as
CagA and VacA. The gene for VacA is polymorphic
and encodes several subtypes of H. pylori
strains that have different roles in gastroduodenal
diseases.10-16
Our study demonstrates a possible linkage of
these more virulent strains with acute aortic
dissection. We identified the prevalence of type I
H. pylori strains in patients who underwent repair
of an acute aortic dissection compared with a
tightly matched homogeneous population of con-
trol subjects. We provided evidence that seroposi-
tivity for the more virulent CagA and VacA s1m1
subtypes is an independent risk marker in acute
Table III. Important clinical and demographic
characteristics of patients with and without type I







Age, years 66 ± 4 63 ± 5 .001
Males 45 (82%) 44 (98%) .04
BMI (kg/m2) 28 ± 2 28 ± 3 1
Previous MI 1 (2%) 2 (3%) .8
Total cholesterol
(mg/dL)
195 ± 30 188 ± 28 .2
HDL (mg/dL) 68 ± 25 74 ± 30 .2
Creatinine (mg/dL) 1.3 ± 0.7 1.3 ± 0.5 .09
History of hypertension 21 (46%) 29 (53%) .6
History of diabetes 9 (20%) 12 (22%) .9
History of peptic ulcer 4 (8.8%) — .07
Smoking status
Ex-smokers 8 (18%) 8 (14%) .8
Current smokers 14 (31%) 18 (33%) .9
Socioeconomic status 44 ± 18 54 ± 19 .008
Physical activity 17 (38%) 16 (29%) .4
Values are mean ± SD or numbers (percentages). Socioeconomic status
is assessed by Hollingshead modified index from 120 to 15 (low, 15--45;
medium, 46--80; and high, 81--120).
BMI, Body mass index; MI, myocardial infarction.
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sociation is made possible are unclear and cannot
be deduced from this study.
Many reports evaluated the presence of H. pylori
in atherosclerotic plaques or in aortic aneurism
specimens with controversial results.5-9 Our results
seem to exclude the involvement of H. pylori in
acute aortic dissection based on a direct interac-
tion of the bacteria with the arterial wall. We failed
to detect any bacterial genomic material directly in
the specimens of resected aortic wall, leaving open
the question of how the infectious agents might af-
fect the aortic wall. A plausible explanation has
been put forward, suggesting that the enhanced
immunologic response evoked by these H. pylori
strains may influence atherogenesis and its
evolution.18 Indeed, bacterial cytotoxins induce
the production of several cytokines (interleukin
1 (IL1) and IL2) that may activate the vascular en-
dothelium to change its own hemostatic control
systems.29 Recently, a cross-mimicry between
CagA and VacA proteins and antigens of the endo-
thelial wall has been demonstrated and has been
postulated to induce endothelial damage.30 In ad-
dition, it has been hypothesized that type I strains
of H. pylori predisposing to gastric atrophy may in-
duce vitamin malabsorption and, therefore, hyper-
homocystinemia, which is a well-documented risk
factor for vascular disease. Finally, the vacuolingcytotoxin, encoded by VacA gene, when released
into the bloodstream might induce degenerative
vacuolization of the endothelium with the same
mechanism described in gastric epithelium.
This study could be limited by the cross-
sectional evaluations in the recruitment of an ap-
propriate control group. To avoid all misleading
interferences by confounding variables and subse-
quent statistical adjustments, we chose preliminar-
ily to enroll a control group selected carefully and
matched fully with the patient group according to
demographic and clinical features and risk factors
for acute aortic dissection. The socioeconomic sta-
tus, which is considered by many investigators to
be the most important multivariable misleading
factor, was assessed carefully by giving a score
that embedded several variables. The additional
limitation of our study is relatively low number of
patients. Nevertheless, our sample size has enough
statistical power to demonstrate an association,
albeit not a causal relationship, between VacA
and CagA-positive strains and aortic dissection.
Indeed, our preliminary results are hypothesis
generating and require future wider and definitive
evaluations.
In conclusion, we report that chronic infection
by CagA-VacA s1m1 subtypes of H. pylori is related
to acute ascending aorta dissections. Many func-
tional aspects of the various H. pylori subtypes, how-
ever, must be elucidated to explain the molecular
mechanisms underlying their action in the arterial
wall. Our results may support the idea that chronic
infection by these virulent bacterial strains may be-
come a new risk factor in the etiopathogenesis of
acute aortic dissections. Strategies aimed at pre-
vent H. pylori infection and eradication, which
have already been used successfully to decrease
the risk of peptic ulcer disease and gastric cancer,
may have some impact on the incidence of acute
aortic dissection. Before trials of antibiotics against
H. pylori for the prevention of acute aortic dissec-
tion can be recommended, however, subsequent
data from prospective studies are necessary.REFERENCES
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